» Articles » PMID: 33665791

Diagnostic Usefulness of Immunohistochemical Evaluation of CD1a Antigen and Polyclonal Anti-leishmania Antibodies in Cutaneous Leishmaniasis

Overview
Date 2021 Mar 5
PMID 33665791
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Different immunohistochemical markers to detect amastigotes in cutaneous leishmaniasis have been proposed with variable diagnostic usefulness.

Objectives: To evaluate the diagnostic usefulness of immunohistochemical amastigotes identification by specific polyclonal anti-Leishmania antibodies and CD1a expression (clone EP3622) in a series of PCR confirmed cutaneous leishmaniasis.

Materials And Methods: Thirty-three skin samples corresponding to PCR confirmed cutaneous leishmaniasis were included in the study. All samples were stained with Hematoxylin-eosin and Giemsa. Moreover, immunohistochemical studies with anti-CD1a and anti-Leishmania antibodies were performed. The patients clinical features and the observed histopathological features were also recorded.

Results: From the selected 33 biopsies, Leishmania spp. amastigotes were detected in 48.4% of cases with conventional Hematoxylin-eosin stain and in 57.5% of cases by Giemsa staining. In 31/33 cases, anti-CD1a allowed us to identify parasitic structures, and in 33/33 cases amastigotes were detected with anti-Leishmania antibodies. Concordance between both techniques, anti-CD1a and anti-Leishmania, was 94% [CI 95%: (79,8%-99,3%)] ; p value <0.05. The sensitivity of anti-CD1a in comparison with the PCR was 94%, with a positive predictive value of 100%. Two cases of low parasitic index were negative for CD1a immunostaining. In cases with high parasitic index, anti-CD1a stained amastigotes in superficial and deep dermis. Only a few cases were originally diagnosed with the available histological techniques, needing PCR for Leishmania spp.

Conclusions: Anti-CD1a antibody seems to be a useful technique to identify amastigotes when PCR and anti-Leishmania antibodies are not available. The sensitivity to detect amastigotes is increased when the CD1a immunostaining is added to the classical Haematoxylin - eosin and Giemsa staining.

Citing Articles

Evaluation of CD1a immunostaining in the diagnosis of cutaneous leishmaniasis caused by in Sri Lanka.

Riyal H, Samaranayake N, Amarathunga P, Munidasa D, Karunaweera N Parasitology. 2024; 151(10):1148-1153.

PMID: 39523649 PMC: 11894021. DOI: 10.1017/S0031182024000799.


Imaging Antigens in Experimentally Infected Macrophages and Dermal Scrapings from Cutaneous Leishmaniasis Lesions in Tunisia.

Saidi N, Galai Y, Ben-Abid M, Boussoffara T, Ben-Sghaier I, Aoun K Microorganisms. 2022; 10(6).

PMID: 35744675 PMC: 9227018. DOI: 10.3390/microorganisms10061157.

References
1.
Akilov O, Khachemoune A, Hasan T . Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol. 2007; 46(2):132-42. DOI: 10.1111/j.1365-4632.2007.03154.x. View

2.
Beena K, Ramesh V, Mukherjee A . Identification of parasite antigen, correlation of parasite density and inflammation in skin lesions of post kala-azar dermal leishmaniasis. J Cutan Pathol. 2004; 30(10):616-20. DOI: 10.1034/j.1600-0560.2003.00125.x. View

3.
Belli A, Rodriguez B, Aviles H, Harris E . Simplified polymerase chain reaction detection of new world Leishmania in clinical specimens of cutaneous leishmaniasis. Am J Trop Med Hyg. 1998; 58(1):102-9. DOI: 10.4269/ajtmh.1998.58.102. View

4.
Dias-Polak D, Geffen Y, Ben-Izhak O, Bergman R . The Role of Histopathology and Immunohistochemistry in the Diagnosis of Cutaneous Leishmaniasis Without "Discernible" Leishman-Donovan Bodies. Am J Dermatopathol. 2017; 39(12):890-895. DOI: 10.1097/DAD.0000000000000861. View

5.
Fernandez-Flores A . A new scenario in the immunohistochemical diagnosis of cutaneous leishmaniasis. J Cutan Pathol. 2017; 44(12):1051-1052. DOI: 10.1111/cup.13040. View